Celanese Corp CE

Healthcare SIC 2820 - Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) NAICS Manufacturing › Chemical Manufacturing › Resin, Synthetic Rubber, and Artificial and Synthetic Fibers and Filaments Manufacturing › Resin and Synthetic Rubber Manufacturing derived NYSE

This Annual Report on Form 10-K includes industry data obtained from industry publications and surveys, as well as our own internal company surveys. Third-party industry publications, surveys and forecasts generally state that the information contained therein has been obtained from sources believed to be reliable.

We are a global chemical and specialty materials company. We are a global producer of high performance engineered polymers that are used in a variety of high-value applications, as well as one of the world's largest producers of acetyl products, which are intermediate chemicals for nearly all major industries. As a recognized innovator in the chemicals industry, we engineer and manufacture a wide variety of products essential to everyday living. Our broad product portfolio serves a diverse set of end-use applications including automotive, chemical additives, construction, consumer and industrial adhesives, medical, consumer electronics, energy storage, filtration, paints and coatings, paper and packaging, industrial applications and textiles. Our products enjoy leading global positions due to our differentiated business models, large global production capacity, operating efficiencies, proprietary technology and competitive cost structures.

Last close 47.71 2026-10-23
Market cap $5.24B 2026-06-30 share count
52-week range 35.13 - 70.70

Valuation FY2025 figures against the last close

P/S0.5x
P/E—
P/FCF6.5x
EV/EBITDA—
Dividend yield0.2%
Diluted EPS-10.64

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $9.54B$10.27B$10.93B$9.67B$8.54B$5.66B$6.30B$7.16B$6.14B$5.39B
Cost of revenue $7.59B$7.93B$8.34B$7.29B$5.86B$4.36B$4.69B$5.18B$4.63B$3.98B
Gross profit $1.95B$2.34B$2.58B$2.38B$2.68B$1.29B$1.61B$1.97B$1.51B$1.41B
R&D $125.0M$130.0M$146.0M$112.0M$86.0M$74.0M$67.0M$72.0M$73.0M$78.0M
SG&A $899.0M$1.03B$1.08B$824.0M$633.0M$482.0M$483.0M$546.0M$496.0M$378.0M
Operating income -$786.0M-$720.0M$1.67B$1.38B$1.95B$664.0M$834.0M$1.33B$857.0M$934.0M
Interest expense $701.0M$676.0M$720.0M$405.0M$91.0M$109.0M$115.0M$125.0M$122.0M$120.0M
Pre-tax income -$1.22B-$1.02B$1.16B$1.42B$2.25B$2.25B$988.0M$1.51B$1.07B$1.03B
Income tax $90.0M$507.0M$795.0M$489.0M$330.0M$247.0M$124.0M$292.0M$213.0M$122.0M
Net income -$1.17B-$1.54B$1.94B$1.89B$1.89B$1.99B$852.0M$1.21B$843.0M$900.0M
EPS, basic -10.64-14.1117.8517.4816.9916.856.888.996.116.21
EPS, diluted -10.64-14.1117.7617.3416.8616.756.848.916.096.18
Shares, diluted (wtd. avg.) 109.5M109.3M109.4M109.2M112.1M118.5M124.7M135.4M138.3M145.7M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $1.26B$962.0M$1.80B$1.51B$536.0M$955.0M$463.0M$439.0M$576.0M$638.0M
Short-term investments ————$10.0M$533.0M$40.0M$31.0M$32.0M$30.0M
Receivables $922.0M$1.12B$1.24B$1.38B$1.16B$792.0M$850.0M$1.02B$986.0M$801.0M
Inventory $2.22B$2.28B$2.36B$2.81B$1.52B$978.0M$1.04B$1.05B$900.0M$720.0M
Total current assets $5.69B$5.13B$6.22B$6.61B$3.81B$3.76B$2.77B$2.87B$2.79B$2.47B
Property, plant and equipment $5.08B$5.27B$5.58B$5.58B$4.19B$3.94B$3.71B$3.72B$3.76B$3.58B
Goodwill $4.17B$5.39B$6.98B$7.14B$1.41B$1.17B$1.07B$1.06B$1.00B$796.0M
Other intangibles $3.18B$3.64B$3.98B$4.11B$735.0M$319.0M$312.0M$310.0M$301.0M$194.0M
Total assets $21.70B$22.84B$26.60B$26.27B$11.97B$10.91B$9.48B$9.31B$9.54B$8.36B
Accounts payable $1.28B$1.23B$1.51B$1.52B$1.16B$797.0M$780.0M$819.0M$807.0M$625.0M
Short-term debt $1.20B$1.50B$1.38B$1.31B$791.0M$496.0M$496.0M$561.0M$326.0M$118.0M
Total current liabilities $3.68B$3.89B$4.07B$4.07B$2.50B$1.97B$1.75B$1.78B$1.56B$1.08B
Long-term debt $12.61B$12.53B$13.40B$13.95B$3.72B$3.67B$3.46B$2.97B$3.31B$2.89B
Retained earnings $9.88B$11.05B$12.93B$11.27B$9.68B$8.09B$6.40B$5.85B$4.92B$4.32B
Total equity $4.05B$5.13B$7.07B$5.64B$4.19B$3.53B$2.51B$2.98B$2.89B$2.59B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $1.15B$966.0M$1.90B$1.82B$1.76B$1.34B$1.45B$1.56B$803.0M$893.0M
Depreciation and amortisation $760.0M$801.0M$706.0M$462.0M$371.0M$350.0M$352.0M$343.0M$305.0M$290.0M
Stock-based compensation $24.0M$32.0M$40.0M$60.0M$95.0M$28.0M$48.0M$71.0M$47.0M$31.0M
Capital expenditure $343.0M$435.0M$568.0M$543.0M$467.0M$364.0M$370.0M$337.0M$267.0M$246.0M
Investing cash flow -$349.0M-$470.0M-$134.0M-$11.14B-$1.12B$592.0M-$493.0M-$507.0M-$549.0M-$439.0M
Financing cash flow -$513.0M-$1.31B-$1.46B$10.29B-$1.04B-$1.47B-$935.0M-$1.17B-$351.0M-$759.0M
Dividends paid $13.0M$307.0M$305.0M$297.0M$304.0M$293.0M$300.0M$280.0M$241.0M$201.0M
Buybacks —$0$0$17.0M$1.00B$650.0M$996.0M$805.0M$500.0M$500.0M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001306830-26-000031.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -5B 0 5B 10B 15B Revenue, FY2016: 5.4B Gross profit, FY2016: 1.4B Net income, FY2016: 900M Revenue, FY2017: 6.1B Gross profit, FY2017: 1.5B Net income, FY2017: 843M Revenue, FY2018: 7.2B Gross profit, FY2018: 2B Net income, FY2018: 1.2B Revenue, FY2019: 6.3B Gross profit, FY2019: 1.6B Net income, FY2019: 852M Revenue, FY2020: 5.7B Gross profit, FY2020: 1.3B Net income, FY2020: 2B Revenue, FY2021: 8.5B Gross profit, FY2021: 2.7B Net income, FY2021: 1.9B Revenue, FY2022: 9.7B Gross profit, FY2022: 2.4B Net income, FY2022: 1.9B Revenue, FY2023: 10.9B Gross profit, FY2023: 2.6B Net income, FY2023: 1.9B Revenue, FY2024: 10.3B Gross profit, FY2024: 2.3B Net income, FY2024: -1.5B Revenue, FY2025: 9.5B Gross profit, FY2025: 2B Net income, FY2025: -1.2B FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $5.39B $6.14B $7.16B $6.30B $5.66B $8.54B $9.67B $10.93B $10.27B $9.54B
Gross profit $1.41B $1.51B $1.97B $1.61B $1.29B $2.68B $2.38B $2.58B $2.34B $1.95B
Net income $900.0M $843.0M $1.21B $852.0M $1.99B $1.89B $1.89B $1.94B -$1.54B -$1.17B

Recent filings and events

  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Results announced Item 2.02
  • Regulation FD disclosure Item 7.01
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Officer or director change Item 5.02
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2820

TickerCompanyMarket capP/ERevenue growth
CTA-PB EIDP, Inc. — — —